Compass

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

Bed Bath & Beyond (BBBY) to acquire Fathom (FTHM) in all-stock Everything Home expansion

$BBBY to acquire Fathom Holdings for $53.38M in all-stock deal expanding Marcus Lemonis's Everything Home strategy. Read the full executive analysis here.

bySrinath

June 20, 2026

Compass and Anywhere Real Estate strike $10bn merger deal: Will scale and diversification reshape U.S. housing?

Compass and Anywhere Real Estate announce $10B all-stock merger. Find out how this deal is reshaping the real estate sector and what it means for investors.

byPallavi Madhiraju

September 22, 2025

The Latest

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

Bed Bath & Beyond (BBBY) to acquire Fathom (FTHM) in all-stock Everything Home expansion

Compass and Anywhere Real Estate strike $10bn merger deal: Will scale and diversification reshape U.S. housing?

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

SAMILBIO expands Chaeyun skincare with two November launches as K-beauty exports reach $11.1bn

Schneider Electric Infrastructure (SCHNEIDER) shares fall 3.5% despite new factory expansion: What will November results reveal?

Haleon (HLN) near 319p: Does a 15% share-price crash make its valuation attractive after the growth downgrade?

Ethan Allen will split CEO and chair roles, but who gets to choose Farooq Kathwari’s successor?